MDS precursor conditions
Clonal cytopenia of undetermined significance
Clonal hematopoiesis of indeterminate potential
MDS-related mutations
ASXL1
DNMT3A
EZH2
GATA2
IDH1
IDH2
NRAS
RUNX1
SF3B1
SRSF2
STAG2
TET2
TP53
U2AF1
WT1
MDS/MPN
BCR–ABL1-negative atypical chronic myeloid leukemia
Chronic myelomonocytic leukemia
MDS/MPN with ring sideroblasts and thrombocytosis
MDS/MPN, unclassifiable
Myelodysplastic syndromes
MDS with excess blasts
MDS with isolated del(5q)
MDS with multilineage dysplasia
MDS with ring sideroblasts
MDS with single-lineage dysplasia
MDS, unclassifiable
Risk
COVID-19
Higher-risk
Lower-risk
Therapy-related myeloid neoplasms
Therapy-related MDS
Therapy-related MDS/MPN